http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20180096407-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_55a854abe5a37b075d9a25a1cfcb46eb |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-308 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-555 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-555 |
filingDate | 2017-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6e66964f3e0a16388a17fe49135dc59 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d659f7d1ea12809eb01706c7e9841aad http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c38b4c809021a6cc8eb816f87b3cd162 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7563a236a80ce0343754413fce479165 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8114a89f24a70980acb06056768f7497 |
publicationDate | 2018-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-20180096407-A |
titleOfInvention | Pharmaceutical composition for treating cancer with suppressed side effects in the immune system |
abstract | The present invention relates to a pharmaceutical composition for cancer treatment comprising coumarin or a pharmaceutically acceptable salt thereof as an active ingredient capable of preventing or treating immune system side effects induced by an anti-cancer agent, a pharmaceutical composition for the treatment of cancer which comprises coumarin or a pharmaceutically acceptable salt thereof and an anti- , A pharmaceutical composition for treating cancer in which side effects are suppressed and safety is increased and a health functional food for preventing or ameliorating side effects of the immune system induced by an anticancer agent containing coumarin or a pharmaceutically acceptable salt thereof as an active ingredient ≪ / RTI > The coumarin provided by the present invention can reduce the immune system side effects caused by administration of various platinic anticancer drugs, and thus can be widely used for safe cancer treatment using platinic anticancer drugs. |
priorityDate | 2017-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 83.